关注
Aakash Desai
Aakash Desai
在 mayo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
A Desai, S Sandhu, JP Lai, DS Sandhu
World journal of hepatology 11 (1), 1, 2019
2642019
Hepatitis-B vaccine response in inflammatory bowel disease patients: a systematic review and meta-analysis
GS Kochhar, BP Mohan, SR Khan, S Chandan, LL Kassab, S Ponnada, ...
Inflammatory bowel diseases 27 (10), 1610-1619, 2021
202021
Efficacy of paxlovid and lagevrio for COVID-19 infection in patients with inflammatory bowel disease: a propensity-matched study
JG Hashash, A Desai, GS Kochhar, FA Farraye
Clinical Gastroenterology and Hepatology 21 (3), 841, 2023
172023
Risk of de‐novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications
GS Kochhar, A Desai, A Syed, A Grover, S El Hachem, H Abdul‐Baki, ...
Alimentary Pharmacology & Therapeutics 51 (11), 1067-1075, 2020
172020
Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease
GS Kochhar, A Desai, F Caldera, S El Hachem, E Aoun, D Sandhu, ...
Vaccine 39 (30), 4199-4202, 2021
162021
Hepatocellular carcinoma in noncirrhotic liver: a comprehensive review. World J Hepatol. 2019; 11 (1): 1–18
A Desai, S Sandhu, JP Lai, DS Sandhu
12
Effect of 2 vs 3 doses of COVID-19 vaccine in patients with inflammatory bowel disease: a population-based propensity matched analysis
A Desai, P Deepak, RK Cross, J Murone, FA Farraye, RC Ungaro, ...
Inflammatory bowel diseases 29 (10), 1563-1571, 2023
102023
Quantifying risk factors for ischemic colitis: A nationwide, retrospective cohort study
PA Twohig, A Desai, J Skeans, N Waghray
Indian Journal of Gastroenterology 39, 398-404, 2020
102020
Clinical efficacy, timing, and outcomes of ERCP for management of bile duct leaks: a nationwide cohort study
A Desai, P Twohig, S Trujillo, S Dalal, GS Kochhar, DS Sandhu
Endoscopy international open 9 (02), E247-E252, 2021
72021
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J Hepatol. 2019; 11: 1–18
A Desai, S Sandhu, JP Lai, DS Sandhu
Received, 2019
62019
Efficacy of biologic and small molecule agents as second‐line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: a propensity‐matched cohort study
GS Kochhar, A Desai, FA Farraye, RK Cross, S El‐Hachem, PS Dulai, ...
Alimentary Pharmacology & Therapeutics 58 (3), 297-308, 2023
52023
The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A Propensity Matched Study
EL Barnes, A Desai, GS Kochhar
Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022
52022
Development of inflammatory bowel Disease in HIV patients: a Danish cohort study (1983–2018) with American validation (1999–2018)
R Elmahdi, GS Kochhar, AT Iversen, KH Allin, PS Dulai, A Desai, T Jess
Gastro hep advances 1 (6), 1114-1121, 2022
52022
Risk of post-sphincterotomy bleeding with antiplatelet and anticoagulant use: a propensity-matched analysis of the US Collaborative Network
S Chandan, A Desai, DS Dahiya, D Ramai, BP Mohan, A Facciorusso, ...
Gastrointestinal endoscopy 97 (6), 1129-1136. e3, 2023
42023
Effect of bariatric surgery on disease outcomes in patients with inflammatory bowel disease: a US-based propensity matched cohort study
A Desai, JG Hashash, G Baker, FA Farraye, N Waghray, GS Kochhar
Journal of Clinical Gastroenterology 58 (5), 447-453, 2024
32024
Chronic pancreatitis and risk of atherosclerotic cardiovascular disease: a US cohort propensity-matched study
A Desai, S Chandan, D Ramai, V Kaul, GS Kochhar
Pancreas 52 (1), e21-e28, 2023
32023
Su1538 clinical efficacy and outcomes of ercp for the management of bile duct leaks: a nationwide cohort study
A Desai, P Twohig, S Trujillo, S Dalal, G Kochhar, DS Sandhu
Gastrointestinal Endoscopy 91 (6), AB370, 2020
32020
Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study
A Desai, JG Hashash, GS Kochhar, MS Hayney, F Caldera, FA Farraye
Journal of Crohn's and Colitis 18 (6), 828-835, 2024
22024
Addressing the risks of respiratory syncytial virus for patients with inflammatory bowel disease in the era of novel vaccines
RA Smith, A Desai, JG Hashash, MS Hayney, FA Farraye, F Caldera
Inflammatory Bowel Diseases 29 (11), 1842-1845, 2023
22023
Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure prophylaxis for COVID-19 in patients with inflammatory bowel disease: a propensity matched cohort study
A Desai, JG Hashash, GS Kochhar, FA Farraye
Crohn's & Colitis 360 5 (3), otad047, 2023
22023
系统目前无法执行此操作,请稍后再试。
文章 1–20